You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 3,932,645


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 3,932,645
Title: Pharmaceutical compositions containing unsymmetrical esters of 1,4-dihydropyridine 3,5-dicarboxylic acid
Abstract:Pharmaceutical compositions containing unsymmetrical esters of 1,4-dihydropyridine 3,5-dicarboxylic acids as the active ingredient and methods of using same. The said ingredients are unsymmetrical 1,4-dihydropyridine 3,5-dicarboxylates which are substituted at position-4 of the dihydropyridine nucleus by phenyl which contains at least one nitro, cyano, azido, alkylthio, or alkylsulphonyl substituent. The compositions have a cardiovascular activity which makes them useful for effecting coronary vascular dilation and, also, they have utility in the treatment of hypertension.
Inventor(s): Meyer; Horst (Wuppertal-Elberfeld, DT), Bossert; Friedrich (Wuppertal-Elberfeld, DT), Vater; Wulf (Opladen, DT), Stoepel; Kurt (Wuppertal-Vohwinkel, DT)
Assignee: Farbenfabriken Bayer AG (DT)
Application Number:05/398,982
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

When navigating the complex landscape of U.S. patents, understanding the scope and claims of a patent is crucial for inventors, researchers, and business professionals. This article will delve into the specifics of patent claims, the patenting process, and the implications of patent scope, using the context of U.S. Patent 3,932,645 as a reference point, although the specific details of this patent are not provided here.

What are Patent Claims?

Patent claims are the heart of a patent application, defining the scope of the invention for which protection is sought. These claims must be clear, concise, and supported by the description in the patent specification[4].

Types of Claims

  • Independent Claims: These stand alone and do not refer to any other claim. They define the broadest scope of the invention.
  • Dependent Claims: These refer back to an independent claim and narrow down the scope of the invention[3].

The Patenting Process

The journey to obtaining a U.S. patent involves several key steps:

Provisional Patent Application

This is often the first step, providing a temporary protection for one year. It allows the inventor to file a non-provisional patent application within this period[4].

Non-Provisional Patent Application

This is the formal application that starts the national phase of the patenting process. It undergoes a thorough review by a patent examiner to determine its patentability[4].

Patent Prosecution

During this phase, the patent examiner reviews the application, and the inventor may need to argue or amend the claims to address any objections. If the examiner rejects the claims, the inventor can appeal to the Patent Trial and Appeal Board (PTAB) or the federal courts[4].

Patent Scope and Its Measurement

Patent scope is a critical aspect of patent quality and can be measured in various ways:

Independent Claim Length and Count

Research has shown that independent claim length and count can be simple yet effective metrics for measuring patent scope. Narrower claims, as indicated by shorter lengths and fewer counts, are often associated with a higher probability of grant and a shorter examination process[5].

Patent Maintenance Payments and Forward Citations

These metrics can also indicate the scope and validity of a patent. Patents with narrower claims tend to have higher maintenance payments and more forward citations, suggesting their relevance and impact[5].

Obviousness-Type Double Patenting (ODP)

ODP is a doctrine that prevents the same inventor from obtaining multiple patents for the same invention. This is particularly relevant when dealing with continuation-in-part patents or patents with different expiration dates due to Patent Term Adjustments (PTA)[1].

Example from In re Cellect

In the case of In re Cellect, the Federal Circuit addressed ODP in the context of patents with PTA. The court held that ODP analysis should be based on the adjusted expiration date of the patent, ensuring that patents within the same family do not extend beyond the original expiration date of the earliest patent in the family[1].

Patent Term Adjustments (PTA) and Terminal Disclaimers

PTA can extend the term of a patent to compensate for delays during the prosecution process. However, when dealing with ODP, terminal disclaimers may be required to ensure that the later-granted patent does not extend beyond the expiration date of the earlier patent[1].

Commercial and Strategic Implications

Understanding the scope and claims of a patent is crucial for commercial and strategic decisions:

Licensing and Litigation

Broader patents with unclear or overly broad claims can lead to increased licensing and litigation costs, diminishing the incentives for innovation. Narrower, well-defined claims can mitigate these risks[5].

Patent Portfolio Management

Companies must manage their patent portfolios carefully, ensuring that each patent within a family does not infringe on the others and that ODP is addressed appropriately. This involves strategic planning and regular review of patent claims and expiration dates[1].

Key Takeaways

  • Clear and Concise Claims: Patent claims must be clear and supported by the patent specification to ensure effective protection.
  • Patent Scope Metrics: Independent claim length and count are useful metrics for measuring patent scope.
  • ODP and PTA: Understanding ODP and PTA is crucial for managing patent families and ensuring compliance with patent laws.
  • Commercial Implications: The scope and clarity of patent claims have significant commercial and strategic implications.

FAQs

What is the purpose of patent claims in a patent application?

Patent claims define the scope of the invention for which protection is sought, distinguishing the invention from prior art and ensuring that the inventor has exclusive rights to the invention.

How is patent scope measured?

Patent scope can be measured using metrics such as independent claim length and count, patent maintenance payments, and forward citations.

What is Obviousness-Type Double Patenting (ODP)?

ODP is a doctrine that prevents the same inventor from obtaining multiple patents for the same invention, ensuring that patents within the same family do not extend beyond the original expiration date of the earliest patent.

What is the role of Patent Term Adjustments (PTA) in patent law?

PTA extends the term of a patent to compensate for delays during the prosecution process, but it must be considered in ODP analyses to avoid extending the patent term beyond the original expiration date.

Why is it important to manage patent portfolios carefully?

Managing patent portfolios carefully ensures that each patent within a family complies with ODP and PTA regulations, avoids unnecessary litigation, and maximizes the commercial value of the patents.

Sources

  1. In re Cellect, LLC, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. U.S. Patent and Trademark Office (USPTO), USA.gov.
  3. Patent Claims Research Dataset, USPTO.
  4. Intellectual Property Protection, KU Office of Research.
  5. Patent Claims and Patent Scope, SSRN.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 3,932,645

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 3,932,645

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
2117571Apr 10, 1971

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.